Literature DB >> 17804720

Requirement for Rac1 in a K-ras induced lung cancer in the mouse.

Joseph L Kissil1, Marita J Walmsley, Linda Hanlon, Kevin M Haigis, Carla F Bender Kim, Alejandro Sweet-Cordero, Matthew S Eckman, David A Tuveson, Anthony J Capobianco, Victor L J Tybulewicz, Tyler Jacks.   

Abstract

Given the prevalence of Ras mutations in human cancer, it is critical to understand the effector pathways downstream of oncogenic Ras leading to transformation. To directly assess the requirement for Rac1 in K-ras-induced tumorigenesis, we employed a model of lung cancer in which an oncogenic allele of K-ras could be activated by Cre-mediated recombination in the presence or absence of conditional deletion of Rac1. We show that Rac1 function is required for tumorigenesis in this model. Furthermore, although Rac1 deletion alone was compatible with cell viability and proliferation, when combined with K-ras activation in primary epithelial cells, loss of Rac1 caused a profound reduction in proliferation. These data show a specific requirement for Rac1 function in cells expressing oncogenic K-ras.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17804720     DOI: 10.1158/0008-5472.CAN-07-2300

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  87 in total

Review 1.  Genetically Engineered Mouse Models of K-Ras-Driven Lung and Pancreatic Tumors: Validation of Therapeutic Targets.

Authors:  Matthias Drosten; Carmen Guerra; Mariano Barbacid
Journal:  Cold Spring Harb Perspect Med       Date:  2018-05-01       Impact factor: 6.915

2.  Requirement of c-Jun NH(2)-terminal kinase for Ras-initiated tumor formation.

Authors:  Cristina Cellurale; Guadalupe Sabio; Norman J Kennedy; Madhumita Das; Marissa Barlow; Peter Sandy; Tyler Jacks; Roger J Davis
Journal:  Mol Cell Biol       Date:  2011-01-31       Impact factor: 4.272

3.  Wilms tumor 1 (WT1) regulates KRAS-driven oncogenesis and senescence in mouse and human models.

Authors:  Silvestre Vicent; Ron Chen; Leanne C Sayles; Chenwei Lin; Randal G Walker; Anna K Gillespie; Aravind Subramanian; Gregory Hinkle; Xiaoping Yang; Sakina Saif; David E Root; Vicki Huff; William C Hahn; E Alejandro Sweet-Cordero
Journal:  J Clin Invest       Date:  2010-10-25       Impact factor: 14.808

Review 4.  The diverse roles of Rac signaling in tumorigenesis.

Authors:  Natalie A Mack; Helen J Whalley; Sonia Castillo-Lluva; Angeliki Malliri
Journal:  Cell Cycle       Date:  2011-05-15       Impact factor: 4.534

Review 5.  Drugging the undruggable RAS: Mission possible?

Authors:  Adrienne D Cox; Stephen W Fesik; Alec C Kimmelman; Ji Luo; Channing J Der
Journal:  Nat Rev Drug Discov       Date:  2014-10-17       Impact factor: 84.694

6.  Inactivation of SAG/RBX2 E3 ubiquitin ligase suppresses KrasG12D-driven lung tumorigenesis.

Authors:  Hua Li; Mingjia Tan; Lijun Jia; Dongping Wei; Yongchao Zhao; Guoan Chen; Jie Xu; Lili Zhao; Dafydd Thomas; David G Beer; Yi Sun
Journal:  J Clin Invest       Date:  2014-01-16       Impact factor: 14.808

7.  MAP kinase and autophagy pathways cooperate to maintain RAS mutant cancer cell survival.

Authors:  Chih-Shia Lee; Liam C Lee; Tina L Yuan; Sirisha Chakka; Christof Fellmann; Scott W Lowe; Natasha J Caplen; Frank McCormick; Ji Luo
Journal:  Proc Natl Acad Sci U S A       Date:  2019-02-01       Impact factor: 11.205

8.  Rac and Rho GTPases in cancer cell motility control.

Authors:  Matteo Parri; Paola Chiarugi
Journal:  Cell Commun Signal       Date:  2010-09-07       Impact factor: 5.712

Review 9.  Mouse models for lung cancer.

Authors:  Min-chul Kwon; Anton Berns
Journal:  Mol Oncol       Date:  2013-02-19       Impact factor: 6.603

10.  Regulation of lung cancer metastasis by Klf4-Numb-like signaling.

Authors:  Valentina Vaira; Alice Faversani; Nina M Martin; David S Garlick; Stefano Ferrero; Mario Nosotti; Joseph L Kissil; Silvano Bosari; Dario C Altieri
Journal:  Cancer Res       Date:  2013-02-25       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.